| 中文名 |
N-亚硝基二苯胺
|
| 英文名 |
N-Nitrosodiphenylamine
|
| 中文别名 |
亚硝基二苯胺
二苯亚硝胺
高效阻聚剂N-NO
防焦剂NA
防焦剂NA
N-亚硝基-N-苯基-苯胺
二苯基亚硝胺
N-亞硝二苯胺
高效阴聚剂N-NO
|
| 英文别名 |
N-NITROSO-DIPHENYLAMINE
Ndpa
Ortard
NdphA
N-Nitroso-N-phenylaniline
Sconoc
TJB
MFCD00019920
Vultrol
Benzenamine, N-nitroso-N-phenyl-
Redax
delacj
EINECS 201-663-0
|
| 密度 |
1.1±0.1 g/cm3
|
| 沸点 |
346.5±15.0 °C at 760 mmHg
|
| 熔点 |
65-66 °C
|
| 分子式 |
C12H10N2O
|
| 分子量 |
198.221
|
| 闪点 |
163.4±20.4 °C
|
| 精确质量 |
198.079315
|
| PSA |
32.67000
|
| LogP |
3.13
|
| 外观性状 |
橙色至棕色固体
|
| 蒸汽压 |
0.0±0.8 mmHg at 25°C
|
| 折射率 |
1.582
|
| 储存条件 |
贮存于阴凉、通风库房内,防火、防晒、密闭。
|
| 稳定性 |
在盐酸甲醇溶液中能发生重排反应生成对亚硝基二苯胺。本品易氧化。属有机毒品。
|
| 水溶解性 |
Insoluble
|
| 分子结构 |
1、 摩尔折射率:60.61
2、 摩尔体积(cm3/mol):181.5
3、 等张比容(90.2K):467.6
4、 表面张力(dyne/cm):44.0
5、 极化率(10-24cm3):24.02
|
| 计算化学 |
1.疏水参数计算参考值(XlogP):无
2.氢键供体数量:0
3.氢键受体数量:3
4.可旋转化学键数量:2
5.互变异构体数量:无
6.拓扑分子极性表面积32.7
7.重原子数量:15
8.表面电荷:0
9.复杂度:178
10.同位素原子数量:0
11.确定原子立构中心数量:0
12.不确定原子立构中心数量:0
13.确定化学键立构中心数量:0
14.不确定化学键立构中心数量:0
15.共价键单元数量:1
|
| 更多 |
1. 性状:黄色至棕色粉末或片状结晶体
2. 密度(g/cm3):1.24
3. 相对蒸汽密度(g/mL,空气=1):未确定
4. 熔点(ºC):66.5
5. 沸点(ºC,常压):268
6. 沸点(ºC,5.2kPa):未确定
7. 折射率:未确定
8. 闪点(ºC):未确定
9. 比旋光度(º):未确定
10. 自燃点或引燃温度(ºC):未确定
11. 蒸气压(kPa,25ºC):未确定
12. 饱和蒸气压(kPa,60ºC):未确定
13. 燃烧热(KJ/mol):未确定
14. 临界温度(ºC):未确定
15. 临界压力(KPa):未确定
16. 油水(辛醇/水)分配系数的对数值:未确定
17. 爆炸上限(%,V/V):未确定
18. 爆炸下限(%,V/V):未确定
19. 溶解性:不溶于水(0.0035 g/100 mL)。易溶于丙酮、热苯、热乙醇、醋酸乙酯、二氯甲烷、四氯化碳、二硫化碳,N,N-二甲基甲酰胺和乙醚等有机溶剂。
|
毒理学数据:
1、毒性分级 中毒 2、急性毒性 口服-大鼠 LD50: 1825 毫克/公斤; 口服-小鼠 LD50: 1860 毫克/公斤。 3、刺激数据 眼睛-兔子500 毫克/24小时 轻度。
4、对皮肤、眼镜及上呼吸道有刺激性,长期接触会引起肝功能及血象的变异,并引起神经衰弱等症状。生产过程中要注意设备的密闭性和车间的通风,操作人员应穿戴防护用具。不得在生产场所中用膳。
生态学数据:
本品对水体稍有污染。
CHEMICAL IDENTIFICATION
-
RTECS NUMBER :
-
JJ9800000
-
CHEMICAL NAME :
-
Diphenylamine, N-nitroso-
-
CAS REGISTRY NUMBER :
-
86-30-6
-
BEILSTEIN REFERENCE NO. :
-
0909531
-
LAST UPDATED :
-
199710
-
DATA ITEMS CITED :
-
59
-
MOLECULAR FORMULA :
-
C12-H10-N2-O
-
MOLECULAR WEIGHT :
-
198.24
-
WISWESSER LINE NOTATION :
-
ONNR&R
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
-
TYPE OF TEST :
-
Standard Draize test
-
ROUTE OF EXPOSURE :
-
Administration into the eye
-
SPECIES OBSERVED :
-
Rodent - rabbit
-
TYPE OF TEST :
-
LD50 - Lethal dose, 50 percent kill
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - rat
-
DOSE/DURATION :
-
1825 mg/kg
-
TOXIC EFFECTS :
-
Lungs, Thorax, or Respiration - cyanosis
-
TYPE OF TEST :
-
LD50 - Lethal dose, 50 percent kill
-
ROUTE OF EXPOSURE :
-
Unreported
-
SPECIES OBSERVED :
-
Rodent - rat
-
DOSE/DURATION :
-
3 gm/kg
-
TOXIC EFFECTS :
-
Details of toxic effects not reported other than lethal dose value
-
TYPE OF TEST :
-
LD50 - Lethal dose, 50 percent kill
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - mouse
-
DOSE/DURATION :
-
1860 mg/kg
-
TOXIC EFFECTS :
-
Lungs, Thorax, or Respiration - cyanosis
-
TYPE OF TEST :
-
LD50 - Lethal dose, 50 percent kill
-
ROUTE OF EXPOSURE :
-
Intraperitoneal
-
SPECIES OBSERVED :
-
Rodent - mouse
-
DOSE/DURATION :
-
1 gm/kg
-
TOXIC EFFECTS :
-
Details of toxic effects not reported other than lethal dose value
-
TYPE OF TEST :
-
LD50 - Lethal dose, 50 percent kill
-
ROUTE OF EXPOSURE :
-
Administration onto the skin
-
SPECIES OBSERVED :
-
Rodent - rabbit
-
DOSE/DURATION :
-
>7940 mg/kg
-
TOXIC EFFECTS :
-
Behavioral - food intake (animal) Behavioral - changes in motor activity (specific assay)
-
TYPE OF TEST :
-
TDLo - Lowest published toxic dose
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - rabbit
-
DOSE/DURATION :
-
2440 mg/kg/17W-I
-
TOXIC EFFECTS :
-
Nutritional and Gross Metabolic - weight loss or decreased weight gain
-
TYPE OF TEST :
-
TDLo - Lowest published toxic dose
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - rat
-
DOSE/DURATION :
-
140 gm/kg/2Y-C
-
TOXIC EFFECTS :
-
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - tumors
-
TYPE OF TEST :
-
TDLo - Lowest published toxic dose
-
ROUTE OF EXPOSURE :
-
Administration onto the skin
-
SPECIES OBSERVED :
-
Rodent - mouse
-
DOSE/DURATION :
-
800 mg/kg/20W-I
-
TOXIC EFFECTS :
-
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - bronchiogenic carcinoma Tumorigenic - increased incidence of tumors in susceptible strains
-
TYPE OF TEST :
-
TD - Toxic dose (other than lowest)
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - rat
-
DOSE/DURATION :
-
170 gm/kg/2Y-C
-
TOXIC EFFECTS :
-
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - tumors
-
TYPE OF TEST :
-
TD - Toxic dose (other than lowest)
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - rat
-
DOSE/DURATION :
-
2800 gm/kg/2Y-C
-
TOXIC EFFECTS :
-
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - tumors Skin and Appendages - tumors
-
TYPE OF TEST :
-
TD - Toxic dose (other than lowest)
-
ROUTE OF EXPOSURE :
-
Administration onto the skin
-
SPECIES OBSERVED :
-
Rodent - mouse
-
DOSE/DURATION :
-
800 mg/kg/20W-I
-
TOXIC EFFECTS :
-
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors
-
TYPE OF TEST :
-
TD - Toxic dose (other than lowest)
-
ROUTE OF EXPOSURE :
-
Intraperitoneal
-
SPECIES OBSERVED :
-
Rodent - rat
-
DOSE/DURATION :
-
7700 mg/kg/77W-I
-
TOXIC EFFECTS :
-
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Liver - tumors Endocrine - tumors
-
TYPE OF TEST :
-
TD - Toxic dose (other than lowest)
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - mouse
-
DOSE/DURATION :
-
1750 gm/kg/2Y-I
-
TOXIC EFFECTS :
-
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Kidney, Ureter, Bladder - tumors
-
TYPE OF TEST :
-
TD - Toxic dose (other than lowest)
-
ROUTE OF EXPOSURE :
-
Oral
-
SPECIES OBSERVED :
-
Rodent - rat
-
DOSE/DURATION :
-
146 gm/kg/2Y-C
-
TOXIC EFFECTS :
-
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - tumors
-
TYPE OF TEST :
-
Specific locus test
MUTATION DATA
-
TYPE OF TEST :
-
Sister chromatid exchange
-
TEST SYSTEM :
-
Rodent - hamster Fibroblast
-
DOSE/DURATION :
-
100 umol/L
-
REFERENCE :
-
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. Volume(issue)/page/year: 58,1635,1977 *** REVIEWS *** IARC Cancer Review:Animal Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 27,213,1982 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 27,213,1982 IARC Cancer Review:Group 3 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 82865 No. of Facilities: 102 (estimated) No. of Industries: 3 No. of Occupations: 19 No. of Employees: 3163 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 82865 No. of Facilities: 137 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 1093 (estimated)
|
【方法一】
由二苯胺与亚硝酸钠在硫酸存在下反应而得。亚硝化反应以乙醇或二甲苯(或氯苯)为溶剂,亚硝酸钠溶液浓度为40%。硫酸浓度为30%,于26℃左右反应2.5-3h。反应的物用水洗至pH=6-7。当采用乙醇溶剂时,烘干后得到固体产品N-亚硝基二苯胺;当采用二甲苯或氯苯作溶剂时获得液体产物,用氯化钙干燥后得液态产品。
| 海关编码 |
2928000090
|
| 中文概述 |
2928000090 其他肼(联氨)及胲(羟胺)的有机衍生物。监管条件:无。增值税率:17.0%。退税率:9.0%。最惠国关税:6.5%。普通关税:20.0%
|
| 申报要素 |
品名, 成分含量, 用途
|
| Summary |
2928000090 other organic derivatives of hydrazine or of hydroxylamine VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%
|
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。